Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | SCK CEN Research Services | Other 11 Sep 2024 | | |
 | EQT Life Sciences Venture Capital and Private Equity Principals | Other 16 Sep 2024 | | |
 | PMV Financial Services | Other 11 Sep 2024 | | |
 | IBA Medical Equipment Manufacturing | Other 11 Sep 2024 | | |
 | Paladin Capital Group Venture Capital and Private Equity Principals | Other 11 Sep 2024 | | |
 | Thuja Capital Venture Capital and Private Equity Principals | Other 31 May 2024 | | |
 | Bayern Kapital Venture Capital and Private Equity Principals | Other 30 Jun 2024 | | |
 | Heal Capital Venture Capital and Private Equity Principals | Other 19 Jul 2024 | | |
 | MIG Capital | Other 30 Jun 2024 | | |
 | Mines Paris - PSL Higher Education, edtech | Other 26 Jul 2024 | | |